T. Cascella

发表

Cardiopulmonary impairment in young women with polycystic ovary syndrome.

F. Manguso, F. Giallauria, C. Vigorito, 2006, The Journal of clinical endocrinology and metabolism.

Relationship Between Growth Hormone/Insulin-Like Growth Factor-1 Axis Integrity and Voluntary Weight Loss After Gastric Banding Surgery for Severe Obesity

M. C. Savanelli, F. Orio, A. Colao, 2010, Obesity surgery.

Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome.

F. Manguso, F. Giallauria, C. Vigorito, 2007, The Journal of clinical endocrinology and metabolism.

Is ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome?

F. Orio, A. Colao, F. Zullo, 2004, Journal of endocrinological investigation.

Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome.

F. Manguso, F. Orio, A. Colao, 2006, Human reproduction.

Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome.

F. Manguso, F. Orio, A. Colao, 2005, The Journal of clinical endocrinology and metabolism.

Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome.

F. Orio, A. Colao, F. Zullo, 2004, The Journal of clinical endocrinology and metabolism.

Insulin‐like growth factor‐binding protein‐2 is required for osteoclast differentiation

L. Maile, D. Clemmons, C. Rosen, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Evidence for altered adipocyte function in polycystic ovary syndrome.

F. Orio, A. Colao, G. Lombardi, 2005, European journal of endocrinology.

Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women

B. Guida, F. Orio, A. Colao, 2005, Journal of endocrinological investigation.

Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.

C. Nappi, F. Orio, F. Zullo, 2004, Human Reproduction.

Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea‐15) in women with polycystic ovary syndrome

F. Manguso, F. Orio, P. Formisano, 2007, Clinical endocrinology.

Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: A case of idiopathic hirsutism?

F. Orio, A. Colao, S. Savastano, 2004, Journal of endocrinological investigation.

Adiponectin levels in women with polycystic ovary syndrome.

F. Orio, A. Colao, R. Vettor, 2003, The Journal of clinical endocrinology and metabolism.

Lack of an Association between Peroxisome Proliferator-Activated Receptor-γ Gene Pro12Ala Polymorphism and Adiponectin Levels in the Polycystic Ovary Syndrome

F. Orio, A. Colao, S. Savastano, 2004 .

The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome.

L. Nardo, F. Manguso, F. Orio, 2005, The Journal of clinical endocrinology and metabolism.

Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?

L. Nardo, F. Orio, A. Colao, 2004, Reproductive biomedicine online.

Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome.

F. Manguso, F. Giallauria, C. Vigorito, 2006, The Journal of clinical endocrinology and metabolism.

Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study.

F. Manguso, F. Orio, A. Colao, 2005, The Journal of clinical endocrinology and metabolism.

RAPID The Increase of Leukocytes as a New Putative Marker of Low-Grade Chronic Inflammation and Early Cardiovascular Risk in Polycystic Ovary Syndrome

L. Nardo, F. Manguso, F. Orio, 2004 .

Lack of electrocardiographic changes in women with polycystic ovary syndrome

F. Manguso, F. Giallauria, C. Vigorito, 2007, Clinical endocrinology.

Erratum: Insulin‐like growth factor‐binding protein‐2 is required for osteoclast differentiation

L. Maile, D. Clemmons, C. Rosen, 2012 .

GH and IGF‐I deficiency are associated with reduced loss of fat mass after laparoscopic‐adjustable silicone gastric banding

M. C. Savanelli, F. Orio, A. Colao, 2008, Clinical endocrinology.

Circulating ghrelin concentrations in the polycystic ovary syndrome.

F. Orio, A. Colao, P. Lucidi, 2003, The Journal of clinical endocrinology and metabolism.

Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects.

G. Vitale, A. Colao, S. Savastano, 2008, European journal of endocrinology.

Genetic analysis of the follicle stimulating hormone receptor gene in women with polycystic ovary syndrome

A. Pinchera, P. Vitti, A. Dimida, 2006, Journal of endocrinological investigation.

P-77 Relationships between serum insulin-like growth factor-I levels, blood pressure and glucose tolerance: an observational, exploratory study in 404 subjects

G. Vitale, S. Savastano, G. Lombardi, 2008 .

Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women.

M. Sabbatini, S. Federico, F. Orio, 2004, Human reproduction.

Effects of neridronate treatment in elderly women with osteoporosis

C. Nappi, F. Orio, G. Lombardi, 2005, Journal of endocrinological investigation.

Aldosterone enhances IGF-I-mediated signaling and biological function in vascular smooth muscle cells.

Y. Radhakrishnan, L. Maile, D. Clemmons, 2010, Endocrinology.

Visceral fat and cardiovascular risk in patients with polycystic ovary syndrome

F. Giallauria, I. de Sio, F. Orio, 2009 .

Cardiovascular complications of obesity in adolescents

F. Orio, A. Colao, S. Savastano, 2007, Journal of endocrinological investigation.

Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome.

F. Manguso, F. Giallauria, I. de Sio, 2007, Human reproduction.

Endothelial dysfunction in PCOS: role of obesity and adipose hormones.

F. Orio, A. Colao, G. Rini, 2006, The American journal of medicine.

The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study.

F. Orio, A. Colao, F. Zullo, 2004, The Journal of clinical endocrinology and metabolism.

[Polycystic ovary syndrome: an example of obesity-related cardiovascular complication affecting young women].

F. Giallauria, C. Vigorito, F. Orio, 2016, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome.

F. Orio, A. Colao, S. Savastano, 2004, The Journal of clinical endocrinology and metabolism.

Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects.

G. Vitale, A. Colao, S. Savastano, 2008, European journal of endocrinology.

Growth hormone status in morbidly obese subjects and correlation with body composition

S. Savastano, C. Somma, A. Belfiore, 2006, Journal of endocrinological investigation.

Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women

A. Colao, G. Lombardi, T. Cascella, 2005, Journal of endocrinological investigation.